Product Recalls: June 18, 2025 – July 16, 2025
Health Letter, August 2025
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
For Class 1 recalls, there is a potential for serious injury or death.
For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.
CLASS I
CLASS II
acetaminophen tablets, 325 mg, 100-count bottles. Distributed by: Amazon.com Services LLC. Lot #: AEF124004A, exp. date: 08/31/2026.
duloxetine delayed-release capsules, 40 mg, 30-count bottles. Manufactured by: Towa Pharmaceutical. Lot #: 230199, exp. date: 01/31/2026.
gabapentin capsules, 100 mg, 100 capsules in 10×10 blister pack cartons or 10 capsules (10×1) per bag. Packaged and Distributed by: MAJOR PHARMACEUTICALS. Lot #: M05205, exp. date: 10/2026; Lot #: M05205A or M05205B, exp. date: 10/2026.
metoclopramide tablets, 10 mg, 100-count bottle. Manufactured by: Pliva Hrvatska. Lot #: 5420094, exp. date: 09/30/2027.
metoprolol succinate extended-release tablets, 25 mg, 100- or 500-count bottle. Manufactured by: Granules India Limited. Lot #: 1400008A, exp. date: 12/31/2025; Lot #: 1400008B, exp. date: 12/31/2025.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.